Tsafrir S. Mor

Biochemistry, Genetics and Molecular Biology · Life Sciences

26h-index2.0kcitations73works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Transgenic Plants and Applications(37), Cholinesterase and Neurodegenerative Diseases(21), Plant tissue culture and regeneration(18), HIV Research and Treatment(10), Plant Virus Research Studies(9)

Publications72 total

Environmental Constraints and Development of Solutions
2024
Production of IgG Fusion Proteins Transiently Expressed in <em>Nicotiana benthamiana</em>
Journal of Visualized Experiments·2021· 3 cited
Production of IgG Fusion Proteins Transiently Expressed in <em>Nicotiana benthamiana</em>
Journal of Visualized Experiments·2021
A plant-derived cocaine hydrolase prevents cocaine overdose lethality and attenuates cocaine-induced drug seeking behavior
Progress in Neuro-Psychopharmacology and Biological Psychiatry·2020· 4 citedOpen Access
Codelivery of improved immune complex and virus-like particle vaccines containing Zika virus envelope domain III synergistically enhances immunogenicity
Vaccine·2020· 27 citedOpen Access
Corrigendum to “A heterologous prime-boosting strategy with replicating Vaccinia virus vectors and plant-produced HIV-1 Gag/dgp41 virus-like particles” [Virology 507 (2017) 242–256]
Virology·2019
Author Correction: Plant-expressed cocaine hydrolase variants of butyrylcholinesterase exhibit altered allosteric effects of cholinesterase activity and increased inhibitor sensitivity
Scientific Reports·2018· 1 citedOpen Access
Expression optimization and functional testing of a scorpion toxin/antibody fragment fusion protein, ACDClx, for the immunotherapeutic treatment of glioblastoma
The Journal of Immunology·2018
Plant-expressed cocaine hydrolase variants of butyrylcholinesterase exhibit altered allosteric effects of cholinesterase activity and increased inhibitor sensitivity
Scientific Reports·2017· 38 citedOpen Access
A heterologous prime-boosting strategy with replicating Vaccinia virus vectors and plant-produced HIV-1 Gag/dgp41 virus-like particles
Virology·2017· 4 citedOpen Access
Bacterial expression, correct membrane targeting and functional folding of the HIV-1 membrane protein Vpu using a periplasmic signal peptide
PLoS ONE·2017· 10 citedOpen Access
IMST-50. DEVELOPMENT AND EXPRESSION OF A T CELL ENGAGER TARGETED TO GLIOBLASTOMA BY CHLOROTOXIN
Neuro-Oncology·2016Open Access
Subunit Vaccines Produced Using Plant Biotechnology
2016· 2 cited
Immunological Characterization of Plant-Based HIV-1 Gag/Dgp41 Virus-Like Particles
PLoS ONE·2016· 22 citedOpen Access
The case for plant-made veterinary immunotherapeutics
Biotechnology Advances·2016· 53 cited
Biophysical Characterization of a Vaccine Candidate against HIV-1: The Transmembrane and Membrane Proximal Domains of HIV-1 gp41 as a Maltose Binding Protein Fusion
PLoS ONE·2015· 16 citedOpen Access
Molecular pharming’s foot in the FDA’s door: Protalix’s trailblazing story
Biotechnology Letters·2015· 69 citedOpen Access
Mucosal Vaccines from Plant Biotechnology
Mucosal Immunology·2015· 2 citedOpen Access
Meeting Report VLPNPV: Session 5: Plant based technology
Human Vaccines & Immunotherapeutics·2014· 3 citedOpen Access
Recombinant expression, purification, and biophysical characterization of the transmembrane and membrane proximal domains of <scp>HIV</scp>‐1 gp41
Protein Science·2014· 4 citedOpen Access
page 1 of 4Next →

Frequent Co-authors

Brian C. Geyer(15), Hermona Soreq(14), Nobuyuki Matoba(8), Latha Kannan(8), Jacquelyn Kilbourne(8), Hugh S. Mason(7), Itzhak Ohad(6), Irene Cherni(6), Charles J. Arntzen(5), Mrinalini Muralidharan(5), Katherine E. Larrimore(5), Tama Evron(5), Lydia R. Meador(5), Brenda G. Hogue(5), Morgane Bomsel(4), Ryan R. Woods(4), Jeffrey D. Doran(4), Samuel P. Fletcher(4), Sarah A. Kessans(4), Petra Fromme(4)